1. The 2022 infant formula crisis was one of those rare national emergencies that struck at the most intimate and vulnerable moment of family life. It was not a storm, a blackout, or a supply-chain snag that people could shrug off. It was a frantic, sleepless search for food for babies who could not eat anything else. Parents drove for hours, dismantled their routines, rationed precious cans, and begged strangers online for a scoop of Similac. Behind that panic was a terrifying truth: something had gone profoundly wrong in a facility trusted to feed the youngest and most fragile among us. The Department of Justice has now announced a settlement with Abbott Laboratories for more than $384 million, directly linked to that crisis. The settlement relates to the company’s failure to manufacture certain powdered infant formula and nutritional therapy products at its plants in Sturgis, Michigan, and Casa Grande, Arizona, in compliance with federal and state laws, regulations, and contracts. For the government, the nation’s food supply is not a negotiable commodity. It is a basic promise. When that promise is broken, and babies are harmed, there must be consequences. The settlement is a major step toward accountability, but it is also a reminder that the system that failed those families was not a machine that broke down; it was a series of human decisions that put profit before safety, and it needs more than a financial penalty to heal.
2. The legal core of the settlement is a civil resolution under the False Claims Act, and the sums involved are staggering. Abbott Laboratories will pay $348,700,868 to the United States to resolve the federal government’s false claims allegations, and an additional $36,298,172 to certain states for claims settled by their Medicaid and WIC programs. In total, the company will pay more than $384 million. The allegations cover a five-year period, from January 1, 2018, to December 31, 2022, during which the government claims Abbott caused false claims to be submitted to federal and state programs. In plain terms, the government says that Abbott let taxpayer-funded programs buy infant formula that was not manufactured in compliance with the safety standards required by law, and did so knowingly. The settlement resolves the federal government’s claims, but it is not a determination of liability. The company has not admitted wrongdoing under the settlement. Meanwhile, numerous court actions brought by parents remain pending. The case also has a whistleblower dimension under the qui tam provisions of the False Claims Act, which allow private citizens to file suit on behalf of the government and share in the recovery. In this case, three Abbott employees—Scott Millard, Kristine Cooper, and Loren Cooper—will receive $69 million as their share of the federal settlement. Those insiders, people who worked inside the very walls where the problems occurred, helped expose what was happening. Their role underscores a difficult truth: the most dangerous problems are often known to those inside an organization, and the people who speak up are essential to protecting the public.
3. To understand what happened, and why this settlement matters so much, it helps to picture the place at the center of the storm: the Sturgis, Michigan, manufacturing plant. The federal complaint describes conditions that read less like a modern medical facility and more like a neglected industrial building with a dangerously casual attitude toward safety. There were roof leaks, the government said, that allowed water to drip directly over equipment used to produce infant formula. Rather than fixing the leaks permanently, the company reportedly placed rain umbrellas to divert the water. Rain umbrellas. In a plant making food for newborns. That detail alone captures a shocking level of disregard. The complaint also says that Abbott continued to use spray dryers that transformed liquid formula into powdered product, even though corporate leadership knew the dryers had cracks and pits in them. These are not cosmetic flaws. Cracks and pits in food processing equipment can harbor bacteria, hide moisture, and provide a perfect home for pathogens like cronobacter, which can be deadly to infants. And according to the Department of Justice, Abbott made conditions worse by lengthening the number of product batches that passed through the dryers between cleaning cycles. The more batches between cleanings, the greater the risk of build-up and contamination. The government contends that the reason for this change was straightforward: it enabled Abbott to increase production, increase sales, and increase revenue. For a company that makes formula relied upon by millions of families, that trade-off is inexcusable. It is especially disturbing because the government also alleges that Abbott intentionally did not test for bacterial growth in some cases, apparently to avoid obtaining positive test results that would show contamination. And in certain instances where testing did demonstrate “micro” contamination, Abbott reportedly failed to disclose those results when responding to requests from the FDA during inspections in 2019 and 2022. The picture that emerges is of a company not merely negligent, but one making active choices to conceal and continue.
4. The 2022 outbreak itself was a tragedy, not just a regulatory failure. Abbott’s products were linked to an outbreak of cronobacter infections, and two infants died after consuming powdered infant formula made at the Sturgis plant. Cronobacter is a bacterium that can cause severe, life-threatening infections in newborns, particularly premature babies or those with weakened immune systems. It can cause sepsis and meningitis. It is not a germ that should ever be present in formula. The recall that followed swept across several brands and varieties, including Similac, and triggered the severe nationwide shortage that left families scrambling. The shortage included formulas contracted by federal and state governments, meaning that even the most vulnerable families who depended on public nutrition programs were affected. The federal government’s response was firm and deeply personal in its language. Acting Deputy Attorney General Trent McCotter said that Abbott would pay a substantial sum to resolve serious allegations that it violated federal health and safety requirements designed to protect babies. He added, “The Justice Department will act decisively against anyone who puts American families at risk and ensure misconduct carries serious consequences.” Associate Attorney General Stanley E. Woodward, Jr. made the point even more directly: “No company should be gambling on the health and safety of our nation’s infants by allowing unsanitary conditions to persist at a facility manufacturing baby formula.” The USDA’s Office of Inspector General also investigated, and Inspector General John Walk called Abbott’s behavior inexcusable. These are not casual words. They reflect an institutional recognition that the trust placed in infant formula manufacturers is absolute, and that betraying that trust is a form of violence against families.
5. For all the weight of the settlement, there is a sense that money alone is not enough. Food safety expert and Seattle attorney Bill Marler, who has spent decades fighting for safer food, put it plainly. He said the Justice Department found $385 million worth of accountability for how infant formula was made between 2018 and 2022. But he added the crucial caveat: every dollar of it is backward-looking. Not one dollar requires anyone to run a single additional test tomorrow. He noted that Congress can do that part, and that a bill has been pending since March. Marler’s point is essential. A settlement, however large, cannot by itself change the future. It punishes past conduct, but it does not guarantee that the next batch of formula will be made more safely. It does not require additional testing, independent oversight, or transparency. It does not force a company to rethink its cleaning schedules, repair its spray dryers, or stop using umbrellas in the factory. Those changes require regulation, statutory reform, and ongoing vigilance. The pending legislation Marler mentioned is intended to address the safe production of infant formula, to create rules and standards that prevent another crisis. Without such legislation, the same failures could happen again, perhaps with different names and different faces, but with the same target: babies. The settlement should be seen not as the end of the story, but as a call to action for Congress to close the gaps in the system. Accountability is necessary, but prevention is even better. Families need more than compensation after the fact. They need confidence before the fact. They need to know that the formula in the can they feed their child tonight has been made in a facility that is not just hoping for safety, but is required and inspected to achieve it.
6. The settlement itself was the result of a coordinated effort across multiple branches of law enforcement and oversight. The Justice Department’s Civil Division, Commercial Litigation Branch, and Civil Fraud Section worked with the U.S. Attorney’s Office for the Western District of Michigan, with assistance from the USDA’s Office of Inspector General. Trial Attorneys Asha Natarajan and Erin Colleran, along with Assistant U.S. Attorneys Whitney Schnurr and Jacob Carlton, handled the matter. Behind the legal citations and dollar figures are investigators, analysts, lawyers, and whistleblowers who spent years piecing together what happened. Their work matters, not just for this case, but as a warning to any company that might consider cutting corners on food safety. The national food supply, especially infant formula, is non-negotiable. The government’s complaint centered on the fact that more than half of all infant formula purchased in the United States is paid for with USDA funds through the WIC program, which provides nutritional support to women, infants, and children. State Medicaid programs also cover and pay for certain infant formula. Taxpayer money flows directly into the pockets of formula manufacturers. When those companies fail to meet legal and contractual requirements, they are not just hurting individual families. They are defrauding the public trust. The settlement is meant to send a message that such conduct will have consequences. But the real test is what happens next. The parents who lost children to cronobacter infections will forever carry that grief. The parents who stood in empty aisles in 2022 will never forget the fear. And all of us, as a society, must decide whether we want to be a country that simply collects fines from those who harm our children, or a country that does everything in its power to make sure it never happens again. The Abbott settlement is a moment of accountability, but it must also be a moment of change. The food supply is non-negotiable. The safety of our babies is non-negotiable. The next step belongs not just to the courts, but to Congress, to regulators, and to every company that handles the food that feeds our children. They must remember what happened, and they must act as if the lives of infants depend on them. Because they do.